Pulocimab
Based on 1 Customer Validation
Pulocimab (AK109) is an orally active PPARα/γ dual activator with EC50 values of 48 nM and 67 nM, respectively. Pulocimab reduces plasma glucose, improves dyslipidemia, lowers total cholesterol, and raises HDL cholesterol. Pulocimab binds VEGFR2 and blocks VEGF/VEGFR2 signaling, inhibiting angiogenesis, endothelial cell migration, and tumor cell proliferation. Pulocimab can be used for research on type 2 diabetes with dyslipidemia and advanced or metastatic solid tumors.
For research use only. We do not sell to patients.
- Purity : 98.42%
- CAS No.: 2428381-49-9
- Molecular Weight:143.721 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
|
PPARα 48 nM (EC50) |
PPARγ 67 nM (EC50) |
VEGFR2 |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ob/ob[1]
-
Dosage:0.1 mg/kg
-
Administration:p.o.; once daily; for 14 days
-
Result:Reduced plasma glucose.
- Human pluripotent stem cell endothelial-cell differentiation
- Cell migration
- Somatic Cell Culture
- Zigmond Chamber Chemotaxis Assay
- Under-Agarose Cell Migration Assay
- Transwell/Boyden Chamber Migration Assay
- Endothelial Tube Formation Assay
- 3D Collagen/Hydrogel Matrix Migration Assay
- MTT Cell Proliferation Assay
- Cell-Exclusion Zone Migration Assay
- Dunn/Insall Chamber Chemotaxis Assay
- Endothelial Cell Migration/Angiogenic Sprouting Assay
- Scratch/Wound-Healing Migration Assay
- Vascular/Branching Fractal Analysis
- BrdU Incorporation Assay
- Neural Crest/Neuronal Cell Migration Explant Assay
- CFSE Dye Dilution Proliferation Assay
- Dye-dilution cell tracking and proliferation staining
- CCK-8/WST-8 Cell Proliferation Assay
- Protocol for Cell Cycle
- Cell Counting-Based Growth Curve Assay
- Colony Formation (Clonogenic) Assay
- Research Protocol for Metabolic Diseases
- Cell Viability Determination by MTT Colorimetric Assay
- EdU Incorporation Assay (Click Chemistry-Based DNA Synthesis Measurement)
- Ki-67 Immunostaining Proliferation Assay
- PCNA Immunodetection Proliferation Assay
- Protocol for Cell Counting and Cell Density Analysis
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized VEGFR-2 Protein, Human (HEK293, His, HY-P70552) can bind Pulocimab. The EC50 for this effect is 19.88 ng/mL.
Product Details
-
CAS No. 2428381-49-9
-
Accession P35968
-
Synonyms AK109
-
Molecular Weight 143.721 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG1 kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Purity
98.42%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Shipping
Shipping with dry ice.
Purity & Documentation
-
Data Sheet (277 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Pulocimab
- 2428381-49-9
- AK109
- AK 109
- AK-109
- PPAR
- VEGFR
- Peroxisome proliferator-activated receptors
- Vascular endothelial growth factor receptor
- PPARα
- PPARγ
- VEGF/VEGFR2 signaling
- VEGFR2
- angiogenesis
- dyslipidemia
- endothelial cell migration
- solid tumors
- tumor cell proliferation
- type 2 diabetes mellitus
- Inhibitor
- inhibitor
- inhibit